BTCY
BIOTRICITY INC.Company Information
- Company Name
- BIOTRICITY INC.
- CIK
- CIK0001630113
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BTCY: OTC
- Fiscal Year End
- March 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- BTCY
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2021-10-11
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 38,295
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 48,263
- Shares outstanding
- 23,096,373
- Ownership
- 0.21%
Earnings Market Reaction
- Filing date
- 2026-08-19
- Price on filing date
- —
- 1-month reaction
- -21.36%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 6 | 6 | 5 | 6 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | ||||||
| Accounts Receivable Net Current | 2 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 2 | 2 | ||||||
| Inventory Net | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Deposits Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | ||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 6 | 5 | 7 | ||||||
| Accounts Payable And Accrued Liabilities Current | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 8 | 10 | 8 | 7 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 37 | 37 | 24 | 24 | 22 | 21 | 21 | 21 | 21 | 23 | 19 | 18 | ||||||
| Convertible Notes Payable Current | 11 | 11 | 11 | 10 | 10 | 10 | 9 | 8 | 8 | 9 | 8 | 7 | ||||||
| Loans Payable To Bank Current | 15 | 15 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 1 | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 3 | ||||||
| Operating Lease Liability Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Loans Payable Long Term | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Long Term Loans From Bank | - | - | 12 | 12 | 12 | 12 | 12 | 9 | 9 | 10 | 11 | 11 | ||||||
| Derivative Liabilities Noncurrent | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 40 | 39 | 38 | 38 | 37 | 36 | 36 | 34 | 33 | 36 | 32 | 32 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | 2 | 2 | 2 | - | 2 | 2 | 2 | 2 | - | - | - | - | ||||||
| Preferred Stock Value | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 106 | 108 | 108 | 107 | 107 | 107 | 105 | 105 | 104 | 96 | 96 | 93 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -35 | -35 | -34 | -33 | -33 | -32 | -32 | -31 | -30 | -31 | -28 | -27 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | 0 | -0 | 0 | -0 | 0 | 0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -144 | -143 | -142 | -141 | -140 | -139 | -137 | -139 | -139 | -127 | -123 | -120 | ||||||
| Liabilities And Stockholders Equity | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 6 | 5 | 7 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | ||||||
| Common Stock Shares Issued | 20 | 29 | 28 | 27 | 27 | 26 | 24 | 23 | 21 | 9 | 9 | 9 | ||||||
| Shares Outstanding | 20 | 29 | 28 | 27 | 27 | 26 | 24 | 23 | 21 | 9 | 9 | 9 | ||||||
| Common Stock Other Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBIOTRICITY INC. (BTCY) — SEC Financial Statements & Analysis
BIOTRICITY INC. (BTCY) is a surgical & medical instruments & apparatus company, incorporated in NV. BIOTRICITY INC. trades on OTC as: BTCY. BIOTRICITY INC. (BTCY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, BIOTRICITY INC. carries a market cap of $2.86M, a P/E ratio of -1.10x, a P/B ratio of -0.08x, a P/S ratio of 0.17x, an enterprise value of $13.37M, and an EV/EBITDA multiple of 8.50x. On profitability, it posts a gross margin of 81.47%, an operating margin of 9.56%, a net margin of -15.91%, a Return on Equity (ROE) of 7.65%, and a Return on Assets (ROA) of -43.27%. Per share, it reports EPS of $-0.11, diluted EPS of $-0.11, free cash flow per share of $0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 13.40% year-over-year, net income growth of -52.39% year-over-year, and EPS growth of -45.82% year-over-year. On the balance sheet, it maintains a current ratio of 0.15x, a quick ratio of 0.11x, working capital of $-31.75M, a debt-to-equity ratio of -1.12x, a debt ratio of 6.59, an interest coverage ratio of 0.47x, free cash flow of $161.66K (TTM), and net debt of $10.51M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.86M
- P/E TTM
- -1.10x
- EPS TTM
- $-0.11
- P/B TTM
- -0.08x
- ROE TTM
- 7.65%
- ROA TTM
- -43.27%
- Debt To Equity
- -1.12x
- Free Cash Flow TTM
- $161.66K
- Net Revenue TTM Growth 1Y
- 13.40%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOTRICITY INC. in?
BIOTRICITY INC. (BTCY) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does BTCY trade on?
BIOTRICITY INC. (BTCY) trades on the OTC.
Where is BIOTRICITY INC. incorporated?
BIOTRICITY INC. is incorporated in NV.
When was BIOTRICITY INC. (BTCY)'s most recent SEC filing?
BIOTRICITY INC. (BTCY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19.
What is BTCY's market cap?
BIOTRICITY INC. (BTCY) has a market capitalization of $2.86M as of 2026-06-30.
What is BTCY's EPS (earnings per share)?
BIOTRICITY INC. (BTCY)'s trailing twelve month EPS is $-0.11 as of 2026-06-30.
What is BTCY's ROE (return on equity)?
BIOTRICITY INC. (BTCY)'s trailing twelve month Return on Equity (ROE) is 7.65% as of 2026-06-30.
What is BTCY's ROA (return on assets)?
BIOTRICITY INC. (BTCY)'s trailing twelve month Return on Assets (ROA) is -43.27% as of 2026-06-30.
What is BTCY's EV/EBITDA?
BIOTRICITY INC. (BTCY)'s trailing twelve month EV/EBITDA is 8.50x as of 2026-06-30.